Michael Narachi
Director, AMAG Pharmaceuticals.
Companies
- Ultragenyx Pharmaceutical Inc.Board member Feb 24, 2015 to now1
- Eiger BioPharmaceuticals, Inc.Board member Jan 30, 2014 to Jun 5, 20152
- AMAG PharmaceuticalsBoard member Nov 9, 2006 to May 24, 20133
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Ultragenyx Pharmaceutical Inc. RARE40,441 shares4$613.5K at $15.17May 14, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 14, 2026Granted 7,751 shares of Ultragenyx Pharmaceutical Inc.4
- May 15, 2025Granted 5,740 shares of Ultragenyx Pharmaceutical Inc.5
- Jun 18, 2024Granted 5,345 shares of Ultragenyx Pharmaceutical Inc.6
- Jun 7, 2023Granted 3,860 shares of Ultragenyx Pharmaceutical Inc.7
- Jun 24, 2022Granted 3,300 shares of Ultragenyx Pharmaceutical Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARAMAG Pharmaceuticals, Board member
- 4
- 5SEC EDGARForm 4 filed May 19, 2025
- 6SEC EDGARForm 4 filed Jun 20, 2024
- 7SEC EDGARForm 4 filed Jun 9, 2023
- 8SEC EDGARForm 4 filed Jun 28, 2022